688062 迈威生物
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(234,163)(290,223)(956,444)(782,728)(719,171)
投资活动产生之现金流量净额(99,556)(199,315)(291,554)(509,623)(602,803)
筹资活动产生之现金流量净额293,425791,925831,698444,9363,715,810
汇率变动对现金及现金等价物的影响(2,610)(3,614)2331,4032,264
现金及现金等价物净增加/(减少)(42,904)298,773(416,067)(846,011)2,396,100
期初现金及现金等价物余额1,526,3391,227,5661,643,6332,489,64593,545
期末现金及现金等价物余额1,483,4361,526,3391,227,5661,643,6332,489,645